• Exchange: OTC US
  • Sector: Industrials
  • Industry: Electrical Equipment
  • Sub-Industry: Comml & Res Bldg Equip & Sys

Global Immune Technologies Inc

+ Add to Watchlist


0.0012 USD 0.00000.00%

As of 20:10:00 ET on 11/20/2014.

Snapshot for Global Immune Technologies Inc (GIMU)

Open: 0.0012 Day's Range: 0.0012 - 0.0012 Volume: 200
Previous Close: 0.0012 52wk Range: 0.0010 - 0.0097 1-Yr Rtn: -85.00%

Stock Chart for GIMU

No chart data available.
  • GIMU:US 0.0012
  • 1D
  • 1M
  • 1Y
Interactive GIMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GIMU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0040
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.19
Shares Outstanding (M) 157.35
30 Day Average Volume 35,288
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GIMU

No data available

Company Profile & Key Executives for GIMU

Global Immune Technologies, Inc. owns all rights and interests to the drug Trioxolane. The drug acts to reinforce the natural immune system and regulate the production of serotonin, prostaglandin and inflammatory interleukins.

David Michael HolbrookPresident/CEODavid R FrankCFO/Secretary
More Company Profile & Key Executives for GIMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil